For citations:
Geliashvili T.M., Krylov A.S., Bliganov P.I., Dolgushin B.I., Pronin A.I., Tyulyandina A.S., Parnas A.V., Ryzhkov A.D., Pavlova A.V. PSMA‑Targeted Radioligand Therapy with the Radiopharmaceutical 177Lu‑PSMA‑617 in a Patient with Metastatic Castration‑Resistant Prostate Cancer. Journal of oncology: diagnostic radiology and radiotherapy. 2023;6(1):88-96. (In Russ.) https://doi.org/10.37174/2587-7593-2023-6-1-88-96
Email this article 